welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
active, not recruiting
Pediatric Radio Frequency Coils Generic
study id #: NCT01633866
condition: Duchenne Muscular Dystrophy, Musculoskeletal Abnormalities
status: active, not recruiting
purpose:The purpose of this study is to evaluate and optimize advances in radio frequency (RF) coil magnetic resonance imaging (MRI) technology at Cincinnati Children’s Hospital Medical Center (CCHMC).
mechanism of action: No pharmaceutical intervention
results: https://clinicaltrials.gov/ct2/show/results/NCT01633866
last updated: February 14, 2020
study details
study contacts
rareRelated
-
Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional PerformanceThe investigator investigated the effect...
-
Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 SkippingPreU7-53 is a natural history study. The...
-
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and MetforminThe purpose of the study is to show that...
-
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory (PedsQLTM)There isn't specific Health related qual...
-
Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)This is an open-label, extension study o...
-
Microdystrophin Gene Transfer Study in Adolescents and Children With DMDThis is a randomized, controlled, open-l...
-
Finding the Optimum Regimen for Duchenne Muscular DystrophyThe Finding the Optimum Regimen for Duch...
-
PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients...PTC Therapeutics, Inc. today announced t...
-
Cardiac MRI Biomarkers for Duchenne Muscular DystrophyDuchenne muscular dystrophy (DMD) is a f...
-
Antisense Therapeutics to commence muscular dystrophy trialsAntisense Therapeutics is planning to un...
-
Edasalonexent could reduce functional decline in boys with DMD, MoveDMD phase 2 results suggestResults of the Phase 2 MoveDMD trial sho...
-
Capricor trial failure in heart disease might offer another opportunityOn Friday Capricor Therapeutics announce...
